06 Nov Collagen Triple Helix Repeat Containing 1 (CTHRC1) is a prostate cancer therapy response biomarker regulated by androgen receptor (AR) activity

Posted at 15:11h in INNOVATIVE THERAPIES by

ID: 03268

Authors: Gonzalo, Álvaro (1); Macchia, Alice (1,2); Armendariz, Uxue (1); Carracedo, Arkaitz (1,2,4,5); Martínez, Adrián (3); Aytes, Álvaro (3); Valcarcel, Lorea (1,5); Torrano, Verónica (1,4)

Topic: INNOVATIVE THERAPIES